Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)

Sirion Therapeutics

Status and phase: Completed; Phase 3

Conditions: Dry Eye Syndromes

Treatments: Drug: cyclosporine A

Study type: Interventional

Funder types: Industry

Identifiers

NCT00549289

ST-603-006

Details and patient eligibility

About

The purpose of this phase III, open-label study is to determine the safety and tolerability of cyclosporine in the treatment of dry eye syndrome.

Sex: All

Ages: 2+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of dry eye syndrome

Exclusion criteria

• Intraocular or refractive surgery in the study eye within 3 months prior to study start
• Unwilling to discontinue use of contact lenses during the study
• Pregnancy or lactation